Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-08-24 | SANGAMO THERAPEUTICS, INC | Willoughby Scott B.
(SVP, GEN. COUNSEL & SECRETARY) |
F | Common Stock | D | 2801 | $0.86 - $0.86 | $2,408 |
| 2024-08-24 | SANGAMO THERAPEUTICS, INC | Pooler Amy
(VP, HEAD OF RESEARCH) |
F | Common Stock | D | 1196 | $0.86 - $0.86 | $1,027 |
| 2024-08-24 | SANGAMO THERAPEUTICS, INC | Duraibabu Prathyusha
(SVP, CHIEF FINANCIAL OFFICER) |
F | Common Stock | D | 3158 | $0.86 - $0.86 | $2,715 |
| 2024-08-24 | SANGAMO THERAPEUTICS, INC | Dubois-Stringfell...
(SVP-CHIEF DEVELOPMENT OFFICER) |
F | Common Stock | D | 3295 | $0.86 - $0.86 | $2,832 |
| 2024-08-24 | SANGAMO THERAPEUTICS, INC | Macrae Sandy
(PRESIDENT, CEO AND DIRECTOR) |
F | Common Stock | D | 12753 | $0.86 - $0.86 | $10,967 |
| 2024-08-13 | SANGAMO THERAPEUTICS, INC | Willoughby Scott B.
(SVP, GEN. COUNSEL & SECRETARY) |
F | Common Stock | D | 892 | $0.98 - $0.98 | $869 |
| 2024-06-11 | SANGAMO THERAPEUTICS, INC | Duraibabu Prathyusha
(SVP, CHIEF FINANCIAL OFFICER) |
F | Common Stock | D | 892 | $0.61 - $0.61 | $542 |
| 2024-06-04 | SANGAMO THERAPEUTICS, INC | Smith Karen L.
(Director) |
A | Common Stock | A | 25000 | $0.00 - $0.00 | $0 |
| 2024-06-04 | SANGAMO THERAPEUTICS, INC | PARKER H STEWART
(Director) |
A | Common Stock | A | 25000 | $0.00 - $0.00 | $0 |
| 2024-06-04 | SANGAMO THERAPEUTICS, INC | Meyers James R
(Director) |
A | Common Stock | A | 25000 | $0.00 - $0.00 | $0 |
| 2024-05-24 | SANGAMO THERAPEUTICS, INC | Dubois-Stringfell...
(SVP-CHIEF DEVELOPMENT OFFICER) |
F | Common Stock | D | 3295 | $0.60 - $0.60 | $1,976 |
| 2024-05-24 | SANGAMO THERAPEUTICS, INC | Willoughby Scott B.
(SVP, GEN. COUNSEL & SECRETARY) |
F | Common Stock | D | 2736 | $0.60 - $0.60 | $1,641 |
| 2024-05-24 | SANGAMO THERAPEUTICS, INC | Duraibabu Prathyusha
(SVP, CHIEF FINANCIAL OFFICER) |
F | Common Stock | D | 3158 | $0.60 - $0.60 | $1,894 |
| 2024-05-24 | SANGAMO THERAPEUTICS, INC | Macrae Sandy
(PRESIDENT, CEO AND DIRECTOR) |
F | Common Stock | D | 12753 | $0.60 - $0.60 | $7,651 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |